Connection

Antonio Gasbarrini to Non-alcoholic Fatty Liver Disease

Back to Details
This is a "connection" page, showing publications Antonio Gasbarrini has written about Non-alcoholic Fatty Liver Disease.
Antonio Gasbarrini
Connection Strength
0.682
Non-alcoholic Fatty Liver Disease
  1. NAFLD or comorbidities, that is the question. J Hepatol. 2020 09; 73(3):723.
    View in: PubMed
    Score: 0.105
  2. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. World J Gastroenterol. 2019 Jan 28; 25(4):509-520.
    View in: PubMed
    Score: 0.097
  3. Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(2):795-810.
    View in: PubMed
    Score: 0.096
  4. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. Hepatology. 2019 01; 69(1):107-120.
    View in: PubMed
    Score: 0.093
  5. Helicobacter pylori in metabolic related diseases. Minerva Gastroenterol Dietol. 2018 Sep; 64(3):297-309.
    View in: PubMed
    Score: 0.091
  6. Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting. Int J Biol Markers. 2017 Oct 31; 32(4):e397-e402.
    View in: PubMed
    Score: 0.089
  7. Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. Nutr Metab Cardiovasc Dis. 2018 04; 28(4):369-384.
    View in: PubMed
    Score: 0.088
  8. Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-a on the Liver. Int J Mol Sci. 2018 Jul 27; 19(8).
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.